These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19219944)

  • 21. Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patients.
    Collins R
    Am J Manag Care; 2002 Jan; Suppl():6. PubMed ID: 11833455
    [No Abstract]   [Full Text] [Related]  

  • 22. [What is good for the heart pump also helps in impotence: good sex: an affair of the heart].
    Oberhofer E
    MMW Fortschr Med; 2011 Oct; 153(42):18. PubMed ID: 22053438
    [No Abstract]   [Full Text] [Related]  

  • 23. Who should receive a statin these days? Lessons from recent clinical trials.
    Shepherd J
    J Intern Med; 2006 Oct; 260(4):305-19. PubMed ID: 16961668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 10 questions about statins and stroke.
    Goldstein LB
    Neurologist; 2008 Jul; 14(4):262-4. PubMed ID: 18617855
    [No Abstract]   [Full Text] [Related]  

  • 25. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 26. Stroke prevention, blood cholesterol and statins.
    Amarenco P; Lavallée PC; Labreuche J; Touboul PJ
    Acta Neurol Taiwan; 2005 Sep; 14(3):96-112. PubMed ID: 16252611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aortic atherosclerotic disease and stroke.
    Kronzon I; Tunick PA
    Circulation; 2006 Jul; 114(1):63-75. PubMed ID: 16818829
    [No Abstract]   [Full Text] [Related]  

  • 28. Statins for everyone--(even for those at low risk.) Experts are excited, but the question is whether benefits would outweigh costs.
    Duke Med Health News; 2009 Feb; 15(2):1, 11. PubMed ID: 19358321
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment with hydroxymethylglutaryl coenzyme-A-reductase inhibitors in elderly patients: is it necessary?].
    Alexa ID; Panaghiu L; Ungureanu G
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(4):721-6. PubMed ID: 16610166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction.
    Skinner JS; Minhas R
    Heart; 2007 Jul; 93(7):864-6. PubMed ID: 17569812
    [No Abstract]   [Full Text] [Related]  

  • 31. Preventive Statin Use Recommended by US Task Force.
    Kuehn BM
    Circulation; 2017 Feb; 135(8):806-807. PubMed ID: 28223326
    [No Abstract]   [Full Text] [Related]  

  • 32. Statins reduce peri-procedural complications in carotid stenting.
    Reiff T; Amiri H; Rohde S; Hacke W; Ringleb PA
    Eur J Vasc Endovasc Surg; 2014 Dec; 48(6):626-32. PubMed ID: 25240903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cholesterol embolism syndrome: a rare, but severe complication in patients with atherosclerosis].
    Frank RD
    Dtsch Med Wochenschr; 2012 May; 137(21):1130-4. PubMed ID: 22588660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Process of care for carotid endarterectomy: perioperative medical management.
    Stoner MC; Defreitas DJ
    J Vasc Surg; 2010 Jul; 52(1):223-31. PubMed ID: 20304588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal medical treatment versus carotid endarterectomy: the rationale and design of the Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis (AMTEC) study.
    Kolos I; Loukianov M; Dupik N; Boytsov S; Deev A
    Int J Stroke; 2015 Feb; 10(2):269-74. PubMed ID: 23490405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [HAART influences the lipids].
    Behrens G
    MMW Fortschr Med; 2009 Apr; 151(18):36-8. PubMed ID: 19769073
    [No Abstract]   [Full Text] [Related]  

  • 37. Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality.
    Escárcega RO; Garcia-Carrasco M; Jara LJ; Cervera R
    Lupus; 2009 Apr; 18(5):383-6. PubMed ID: 19318388
    [No Abstract]   [Full Text] [Related]  

  • 38. [Statines for all or individualized lipid lowering therapy?].
    Parhofer K
    MMW Fortschr Med; 2009 Apr; 151(14):100, 102-4; quiz 105. PubMed ID: 19504849
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
    McLaren JE; Michael DR; Ashlin TG; Ramji DP
    Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HDL cholesterol and residual risk of first cardiovascular events.
    Saely CH; Vonbank A; Drexel H
    Lancet; 2010 Nov; 376(9754):1738; author reply 1738-9. PubMed ID: 21093648
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.